Arvinas LLC , 5 Science Park, New Haven, Connecticut 06511, United States.
J Med Chem. 2018 Jan 25;61(2):583-598. doi: 10.1021/acs.jmedchem.7b00635. Epub 2017 Jul 10.
Proteolysis targeting chimeras (PROTACs) are bifunctional molecules that recruit an E3 ligase to a target protein to facilitate ubiquitination and subsequent degradation of that protein. While the field of targeted degraders is still relatively young, the potential for this modality to become a differentiated and therapeutic reality is strong, such that both academic and pharmaceutical institutions are now entering this interesting area of research. In this article, we describe a broadly applicable process for identifying degrader hits based on the serine/threonine kinase TANK-binding kinase 1 (TBK1) and have generalized the key structural elements associated with degradation activities. Compound 3i is a potent hit (TBK1 DC = 12 nM, D = 96%) with excellent selectivity against a related kinase IKKε, which was further used as a chemical tool to assess TBK1 as a target in mutant K-Ras cancer cells.
蛋白水解靶向嵌合体(PROTACs)是一种双功能分子,可招募 E3 连接酶到靶蛋白上,促进该蛋白的泛素化和随后的降解。虽然靶向降解剂领域还相对较年轻,但这种模式具有成为差异化和治疗性现实的强大潜力,以至于学术和制药机构现在都进入了这个有趣的研究领域。在本文中,我们描述了一种基于丝氨酸/苏氨酸激酶 TANK 结合激酶 1(TBK1)鉴定降解剂命中的广泛适用的方法,并概括了与降解活性相关的关键结构元素。化合物 3i 是一个有效的命中(TBK1 DC = 12 nM,D = 96%),对相关激酶 IKKε 具有极好的选择性,进一步被用作化学工具来评估 TBK1 作为突变 K-Ras 癌细胞中的靶标。